SANJAI DAYAL: Open Payments
NPI 1689000655 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$926 in 24 payments from 9 companies in 2025. Trend: 2023 $327 · 2024 $345 · 2025 $926
Food & beverage: $898Education: $27
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $219 |
| Otsuka America Pharmaceutical, Inc. | 5 | $185 |
| Janssen Pharmaceuticals, Inc | 3 | $159 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Lundbeck LLC | 3 | $81 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| ABBVIE INC. | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
Products named: REXULTI, CAPLYTA, SPRAVATO, Auvelity, HETLIOZ, VRAYLAR, UZEDY, COBENFY.
Industry payments across NC — which companies pay providers there.
